Technical Analysis for QLGN - Qualigen Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.40 | 0.00% | 0.00 |
QLGN closed unchanged on Thursday, March 28, 2024, on 1.29 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Hammer Candlestick | Bullish | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Pocket Pivot | Bullish Swing Setup | -0.25% | |
Volume Surge | Other | -0.25% | |
Outside Day | Range Expansion | -0.25% | |
Wide Bands | Range Expansion | -0.25% | |
MACD Bullish Signal Line Cross | Bullish | 3.90% |
Alert | Time |
---|---|
Fell Below 10 DMA | about 21 hours ago |
Gap Down Partially Closed | about 22 hours ago |
2x Volume Pace | about 22 hours ago |
1.5x Volume Pace | about 22 hours ago |
3x Volume Pace | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/13/2023
Qualigen is a biotechnology company focused on developing novel products for the treatment and testing of cancer and infectious diseases. Its current commercial product is the FastPack rapid diagnostic testing system. This "Laboratory in a Pouch" is installed in physician offices, clinics and small hospitals around the world, and quickly detects diseases and medical conditions at the point-of-care. Since its inception almost 20 years ago, FastPack has generated more than $100 million in commercial sales. Qualigen's worldwide distributor for FastPack is Sekisui Diagnostics, a subsidiary of a multibillion-dollar Japanese chemical and technology company. Sekisui owns approximately 15.8% of Qualigen's outstanding common shares.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Chemical Disease Infectious Diseases Clinic Medical Test Novel Products
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Chemical Disease Infectious Diseases Clinic Medical Test Novel Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.25 |
52 Week Low | 0.337 |
Average Volume | 61,636 |
200-Day Moving Average | 0.77 |
50-Day Moving Average | 0.46 |
20-Day Moving Average | 0.39 |
10-Day Moving Average | 0.38 |
Average True Range | 0.04 |
RSI (14) | 45.36 |
ADX | 15.51 |
+DI | 15.98 |
-DI | 16.14 |
Chandelier Exit (Long, 3 ATRs) | 0.39 |
Chandelier Exit (Short, 3 ATRs) | 0.46 |
Upper Bollinger Bands | 0.44 |
Lower Bollinger Band | 0.35 |
Percent B (%b) | 0.56 |
BandWidth | 22.56 |
MACD Line | -0.02 |
MACD Signal Line | -0.03 |
MACD Histogram | 0.0059 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.46 | ||||
Resistance 3 (R3) | 0.46 | 0.43 | 0.45 | ||
Resistance 2 (R2) | 0.43 | 0.41 | 0.43 | 0.45 | |
Resistance 1 (R1) | 0.41 | 0.40 | 0.42 | 0.42 | 0.45 |
Pivot Point | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 |
Support 1 (S1) | 0.37 | 0.37 | 0.38 | 0.38 | 0.35 |
Support 2 (S2) | 0.34 | 0.36 | 0.35 | 0.35 | |
Support 3 (S3) | 0.33 | 0.34 | 0.35 | ||
Support 4 (S4) | 0.34 |